Origin Raises Series B Funding

Why It Matters

The infusion of capital positions Origin to scale AI‑driven women's health services, potentially reshaping pelvic floor therapy and expanding market reach in a fast‑growing digital health segment.

Key Takeaways

• Series B led by SJF Ventures, includes Blue Venture Fund
• Funding supports AI-driven personalized pelvic floor care
• Origin serves over 10,000 doctors nationwide
• New app The Origin Way enhances at‑home therapy
• Angel investors from fertility and wellness sectors joined round

Pulse Analysis

The women's health sector has seen a surge in digital therapeutics, driven by rising awareness of pelvic floor disorders and the convenience of remote care. Traditional physical therapy models are being challenged by AI‑enabled platforms that can tailor exercise regimens, monitor compliance, and predict outcomes. As insurers and employers push for cost‑effective solutions, providers that combine clinical expertise with scalable technology are poised to capture significant market share.

Origin’s Series B round underscores investor confidence in AI‑augmented musculoskeletal care. Led by SJF Ventures, the funding brings together venture capital, a state‑backed development bank, and strategic angels from fertility and wellness backgrounds, creating a network that can accelerate product development and distribution. The Athena engine and its conversational agent GinaGPT aim to personalize treatment pathways, reducing manual charting and enabling real‑time adjustments based on patient feedback. This capital infusion also supports the rollout of The Origin Way app, which bridges in‑clinic sessions with at‑home adherence, a critical factor for long‑term therapeutic success.

Looking ahead, Origin’s expansion could reshape the competitive landscape for women’s pelvic health. By integrating AI, the company not only improves clinical outcomes but also generates valuable data that can inform future research and payer negotiations. As more than 10,000 physicians already prescribe its services, scaling the platform nationally could set new standards for tele‑rehabilitation, attract further institutional investment, and ultimately drive broader adoption of technology‑first approaches in women’s musculoskeletal care.